Medical Imaging Corp.(TW:6637)
NT$54.60+0.10 (+0.18%)
TW:6637
Medical Imaging Corp. financials statements
NT$54.60
At close:+0.10 (+0.18%)
Medical Imaging Corp. (6637) Ratios
Medical Imaging Corp. Ratios
TW:6637's free cash flow for Q2 2026 was NT$-57.85M. For the 2026 fiscal year, TW:6637's free cash flow was decreased by NT$-102.22M and operating cash flow was NT$44.38M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.04 | 3.59 | 2.40 | 2.78 | 1.83 |
| Quick Ratio | 2.08 | 3.27 | 1.91 | 2.54 | 1.61 |
| Cash Ratio | 0.95 | 1.41 | 0.99 | 0.93 | 0.64 |
| Solvency Ratio | 0.30 | 0.74 | 0.55 | 0.63 | 0.39 |
| Operating Cash Flow Ratio | -0.75 | 0.90 | 0.77 | 1.46 | 0.53 |
| Short-Term Operating Cash Flow Coverage | -3.74 | 7.11 | 2.70 | 4.58 | 1.05 |
| Net Current Asset Value | NT$ 390.70M | NT$ 540.67M | NT$ 224.29M | NT$ 199.23M | NT$ 16.94M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.24 | 0.08 | 0.17 | 0.20 | 0.32 |
| Debt-to-Equity Ratio | 0.41 | 0.11 | 0.26 | 0.30 | 0.57 |
| Debt-to-Capital Ratio | 0.29 | 0.10 | 0.21 | 0.23 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.25 | 0.06 | 0.12 | 0.15 | 0.25 |
| Financial Leverage Ratio | 1.71 | 1.33 | 1.54 | 1.51 | 1.79 |
| Debt Service Coverage Ratio | 2.66 | 6.89 | 2.58 | 2.88 | 1.63 |
| Interest Coverage Ratio | 32.67 | 75.06 | 75.46 | 46.30 | 28.84 |
| Debt to Market Cap | 0.23 | 0.04 | 0.08 | 0.14 | 0.28 |
| Interest Debt Per Share | 18.12 | 4.14 | 7.03 | 7.16 | 11.63 |
| Net Debt to EBITDA | 0.32 | -0.88 | -0.32 | -0.01 | 0.64 |
| Profitability Margins | |||||
| Gross Profit Margin | 29.40% | 40.54% | 48.13% | 49.15% | 37.59% |
| EBIT Margin | 19.40% | 25.46% | 25.11% | 30.04% | 22.30% |
| EBITDA Margin | 23.95% | 31.81% | 31.62% | 39.81% | 31.24% |
| Operating Profit Margin | 19.40% | 24.08% | 31.03% | 32.17% | 17.61% |
| Pretax Profit Margin | 20.30% | 25.14% | 24.70% | 29.65% | 16.24% |
| Net Profit Margin | 15.93% | 19.91% | 17.79% | 22.90% | 12.71% |
| Continuous Operations Profit Margin | 15.93% | 19.91% | 17.79% | 21.54% | 17.79% |
| Net Income Per EBT | 78.51% | 79.19% | 72.02% | 77.23% | 78.27% |
| EBT Per EBIT | 104.61% | 104.36% | 79.60% | 92.17% | 92.21% |
| Return on Assets (ROA) | 9.69% | 13.88% | 14.06% | 14.63% | 9.93% |
| Return on Equity (ROE) | 16.56% | 18.45% | 21.58% | 22.16% | 17.73% |
| Return on Capital Employed (ROCE) | 14.81% | 20.89% | 32.83% | 26.22% | 18.38% |
| Return on Invested Capital (ROIC) | 11.05% | 15.99% | 21.46% | 18.52% | 12.27% |
| Return on Tangible Assets | 9.69% | 16.53% | 14.06% | 14.63% | 10.35% |
| Earnings Yield | 9.23% | 7.60% | 6.77% | 10.87% | 8.84% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.89 | 5.40 | 4.94 | 4.15 | 4.00 |
| Payables Turnover | 10.05 | 8.83 | 12.41 | 19.39 | 20.45 |
| Inventory Turnover | 2.19 | 6.55 | 3.25 | 6.27 | 8.75 |
| Fixed Asset Turnover | 4.74 | 3.09 | 2.30 | 1.88 | 2.18 |
| Asset Turnover | 0.61 | 0.70 | 0.79 | 0.64 | 0.78 |
| Working Capital Turnover Ratio | 1.67 | 1.82 | 2.27 | 2.14 | 4.25 |
| Cash Conversion Cycle | 192.48 | 81.95 | 156.89 | 127.32 | 115.01 |
| Days of Sales Outstanding | 62.00 | 67.55 | 73.86 | 87.90 | 91.16 |
| Days of Inventory Outstanding | 166.79 | 55.75 | 112.43 | 58.25 | 41.70 |
| Days of Payables Outstanding | 36.30 | 41.35 | 29.41 | 18.83 | 17.84 |
| Operating Cycle | 228.79 | 123.30 | 186.30 | 146.15 | 132.86 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -11.38 | 8.90 | 7.87 | 11.22 | 4.83 |
| Free Cash Flow Per Share | -12.45 | 7.36 | 4.13 | 9.84 | 3.82 |
| Dividend Paid and CapEx Coverage Ratio | -2.36 | 2.07 | 1.20 | 3.31 | 1.38 |
| Capital Expenditure Coverage Ratio | -10.64 | 5.77 | 2.11 | 8.09 | 4.78 |
| Operating Cash Flow Coverage Ratio | -0.64 | 2.21 | 1.14 | 1.60 | 0.42 |
| Operating Cash Flow to Sales Ratio | -0.25 | 0.25 | 0.25 | 0.49 | 0.17 |
| Free Cash Flow Yield | -16.02% | 7.93% | 4.95% | 20.55% | 9.44% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 10.84 | 13.16 | 14.77 | 9.21 | 11.31 |
| Price-to-Sales (P/S) Ratio | 1.73 | 2.62 | 2.63 | 2.11 | 1.44 |
| Price-to-Book (P/B) Ratio | 1.79 | 2.43 | 3.19 | 2.04 | 2.01 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.24 | 12.62 | 20.21 | 4.87 | 10.60 |
| Price-to-Operating Cash Flow Ratio | -6.83 | 10.43 | 10.61 | 4.27 | 8.38 |
| Price-to-Earnings Growth (PEG) Ratio | 6.37 | 0.54 | 1.67 | 0.20 | -0.56 |
| Enterprise Value Multiple | 7.53 | 7.35 | 7.99 | 5.28 | 5.25 |
| Enterprise Value | 2.10B | 1.94B | 1.72B | 1.02B | 990.29M |
| EV to EBITDA | 7.53 | 7.35 | 7.99 | 5.28 | 5.25 |
| EV to Sales | 1.80 | 2.34 | 2.53 | 2.10 | 1.64 |
| EV to Free Cash Flow | -6.52 | 11.26 | 19.44 | 4.85 | 12.08 |
| EV to Operating Cash Flow | -7.13 | 9.31 | 10.21 | 4.25 | 9.55 |
| Tangible Book Value Per Share | 43.29 | 31.66 | 26.23 | 23.48 | 18.72 |
| Shareholders’ Equity Per Share | 43.29 | 38.22 | 26.23 | 23.48 | 20.18 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.21 | 0.28 | 0.23 | 0.22 |
| Revenue Per Share | 45.00 | 35.43 | 31.82 | 22.72 | 28.16 |
| Net Income Per Share | 7.17 | 7.05 | 5.66 | 5.20 | 3.58 |
| Tax Burden | 0.79 | 0.79 | 0.72 | 0.77 | 0.78 |
| Interest Burden | 1.05 | 0.99 | 0.98 | 0.99 | 0.73 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.11 | 0.16 | 0.17 | 0.19 | 0.15 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Income Quality | -1.59 | 1.26 | 1.00 | 2.16 | 1.06 |
Currency in TWD
